Clade I mpox: affected countries

The clade I mpox outbreak is focused in a number of countries within the African region, as per Figure 1 below. Imported clade I mpox cases outside the African region have been reported in several countries.

Figure 1. African Regionregion countries reporting laboratory confirmed clade I mpox (historic or current)

Given the continuing spread of clade I mpox, please check this webpage regularly for any updates to the countries included. This table is derived from the methodology outlined in the Mpox: scenarios and technical elements of preparedness and response for clade I technical briefing 9.

Table 1. CountriesList reportingof cladecountries Iin mpoxthe whereAfrican thereregion mayreporting becases a risk of clade I mpox exposureduring the 2024 outbreak

Table 2. List of countries in the African region with historical transmission of clade I mpox, with no cases reported during the 2024 outbreak

ThereImported are reports of single imported clade IIb mpox cases in the following countries outside of the African region.region Therewith islimited or no evidenceonward of transmission inhave countrybeen andreported thusin theseveral risk of exposure is considered minimal:countries:

• Canada (with (with reported travel history to a clade I affected African country)
• GermanyGermany has reported two imported clade I mpox cases (with reported travel history to Rwanda)Rwanda and another clade I affected African country), with 3 further cases identified in household contacts of the second reported case.
• India (with (with reported travel history to the United Arab Emirates)
• Sweden (with (with reported travel history to a clade I affected African country)
• Thailand (with (with reported travel history to a clade I affected African country)
• United States (with (with reported travel history to a clade I affected African country)

Thethe United Kingdom has reported an2 imported clade I mpox casecases (with reported travel history to mpox clade I affected countries in Africa), with 3 further cases identified in household contacts.

These countries are not considered as clade I mpox affected for purposes of testing or guidance.guidance, unless an individual reports being a contact of a confirmed case in one of these countries. Reported travel history is not necessarily indicative of acquisition in-country and investigations may be ongoing.